Terrault NA, Lok AS, McMahon BJ, Chang KM, Hwang JP, Jonas MM, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560–1599
Sarin S, Kumar M, Lau G, Abbas Z, Chan H, Chen C, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hep Intl. 2016;10:1–98
Lampertico P, Agarwal K, Berg T, Buti M, Janssen HL, Papatheodoridis G, et al. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67(2):370–398
Lim SG, Baumert TF, Boni C, Gane E, Levrero M, Lok AS, et al. The scientific basis of combination therapy for chronic hepatitis B functional cure. Nat Rev Gastroenterol Hepatol. 2023;20(4):238–253
Article CAS PubMed Google Scholar
Li J, Fan P, Xu Z, Dong Y, Wang F, Hong W, et al. Functional cure of chronic hepatitis B with antiviral treatment in children having high-level viremia and normal or mildly elevated serum aminotransferase. J Clin Trans Hepatol. 2023. https://doi.org/10.14218/JCTH.2023.00014
Zhu S, Zhang H, Dong Y, Wang L, Xu Z, Liu W, et al. Antiviral therapy in hepatitis B virus-infected children with immune-tolerant characteristics: a pilot open-label randomized study. J Hepatol. 2018;68(6):1123–1128
Article CAS PubMed Google Scholar
Zhu S, Dong Y, Wang L, Liu W, Zhao P. Early initiation of antiviral therapy contributes to a rapid and significant loss of serum HBsAg in infantile-onset hepatitis B. J Hepatol. 2019;71(5):871–875
Article CAS PubMed Google Scholar
Zhang Y-T, Liu J, Pan X-B, Gao Y-D, Hu Y-F, Lin L, et al. Successful treatment of infantile hepatitis B with lamivudine: a case report. World J Clin Cases. 2021;9(14):3442
Article PubMed PubMed Central Google Scholar
Li Y, Xiao Y, Li L, Song Y, Zhai X, Liu J, et al. The dynamic changes of HBV quasispecies diversity in infancy after immunoprophylaxis failure: a prospective cohort study. Virol J. 2021;18(1):236
Article CAS PubMed PubMed Central Google Scholar
Mason WS, Gill US, Litwin S, Zhou Y, Peri S, Pop O, et al. HBV DNA integration and clonal hepatocyte expansion in chronic hepatitis B patients considered immune tolerant. Gastroenterology. 2016;151(5):986–98.e4
Article CAS PubMed Google Scholar
Tu T, Zehnder B, Wettengel JM, Zhang H, Coulter S, Ho V, et al. Mitosis of hepatitis B virus-infected cells in vitro results in uninfected daughter cells. JHEP Rep. 2022;4(9): 100514
Article PubMed PubMed Central Google Scholar
Kennedy PT, Sandalova E, Jo J, Gill U, Ushiro-Lumb I, Tan AT, et al. Preserved T-cell function in children and young adults with immune-tolerant chronic hepatitis B. Gastroenterology. 2012;143(3):637–645
Article CAS PubMed Google Scholar
Le Bert N, Gill US, Hong M, Kunasegaran K, Tan DZ, Ahmad R, et al. Effects of hepatitis B surface antigen on virus-specific and global T cells in patients with chronic hepatitis B virus infection. Gastroenterology. 2020;159(2):652–664
Bertoletti A, Boni C. HBV antigens quantity: duration and effect on functional cure. Gut. 2022;71(11):2149–2151
Wu LL, Huang TS, Shyu YC, Wang CL, Wang HY, Chen PJ. Gut microbiota in the innate immunity against hepatitis B virus—implication in age-dependent HBV clearance. Curr Opin Virol. 2021;49:194–202
Article CAS PubMed Google Scholar
Rosenthal P, Ling SC, Belle SH, Murray KF, Rodriguez-Baez N, Schwarzenberg SJ, et al. Combination of entecavir/peginterferon alfa-2a in children with hepatitis B e antigen-positive immune tolerant chronic hepatitis B virus infection. Hepatology. 2019;69(6):2326–2337
Article CAS PubMed Google Scholar
D’Antiga L, Aw M, Atkins M, Moorat A, Vergani D, Mieli-Vergani G. Combined lamivudine/interferon-alpha treatment in “immunotolerant” children perinatally infected with hepatitis B: a pilot study. J Pediatr. 2006;148(2):228–233
Comments (0)